Researchers and end users jointly develop forward-looking health technologies with funding of €4 million

- Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock

- Series C round was supported by both existing and new investors

Although menopause – also known as perimenopause – can significantly impair women's well-being and performance, medical education and support have often been inadequate to date. As part of the joint project “PETRA: AI-supported, educational therapy…

Professor Alexander Meyer will head the institute and in this role also holds the newly created professorship for Artificial Intelligence in Medicine.

Highly Cited Researchers 2025 list published

– Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing

– TK-6302 Clinical Trial Application planned in Q4 2025 for initiation of the Phase 1 ATLAS trial…

Researchers from the Institute of Neurophysiology at Charité – Universitätsmedizin Berlin have uncovered new insights into how a key protein called CLIC1 regulates the movement of immune cells in the brain and shapes their response to danger signals.…

A collaboration led by Max Delbrück Center and University of Bath has uncovered how ancient viral DNA controls a gene linked to placenta development and pre-eclampsia, a life-threatening pregnancy disorder. The research, published in “Genome…

Contrary to common assumptions, a new study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité – Universitätsmedizin Berlin, shows that intermittent fasting (time-restricted eating) with an unchanged calorie intake…

There are gender-specific risks after a kidney transplant. The GeGe4Nephro research project, led by Dr. Matthieu-P. Schapranow from the Hasso Plattner Institute for Digital Engineering, is dedicated to addressing these differences in order to improve…